Ausgabe 8/2015
Inhalt (13 Artikel)
Hepatic myeloid-derived suppressor cells in cancer
José Medina-Echeverz, Tobias Eggert, Miaojun Han, Tim F. Greten
Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity
Masato Muto, Muhammad Baghdadi, Ryuji Maekawa, Haruka Wada, Ken-ichiro Seino
Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
Subhashis Sarkar, Michel van Gelder, Willy Noort, Yunping Xu, Kasper M. A. Rouschop, Richard Groen, Harry C. Schouten, Marcel G. J. Tilanus, Wilfred T. V. Germeraad, Anton C. M. Martens, Gerard M. J. Bos, Lotte Wieten
CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion
Fei Wang, Li Yang, Qun Gao, Lan Huang, Liping Wang, Jing Wang, Shengdian Wang, Bin Zhang, Yi Zhang
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
Joseph P. Balint, Elizabeth S. Gabitzsch, Adrian Rice, Yvette Latchman, Younong Xu, Gerald L. Messerschmidt, Arvind Chaudhry, Michael A. Morse, Frank R. Jones
Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation
Marilène Binsfeld, Muriel Hannon, Eléonore Otjacques, Stéphanie Humblet-Baron, Etienne Baudoux, Yves Beguin, Frédéric Baron, Jo Caers
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study
Riccardo Danielli, Roberto Patuzzo, Anna Maria Di Giacomo, Gianfranco Gallino, Andrea Maurichi, Annabella Di Florio, Ornella Cutaia, Andrea Lazzeri, Carolina Fazio, Clelia Miracco, Leonardo Giovannoni, Giuliano Elia, Dario Neri, Michele Maio, Mario Santinami
Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis
Snezana Zivancevic-Simonovic, Olgica Mihaljevic, Ivana Majstorovic, Suzana Popovic, Slavica Markovic, Olivera Milosevic-Djordjevic, Zorica Jovanovic, Ljiljana Mijatovic-Teodorovic, Dusan Mihajlovic, Miodrag Colic
Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study
Katy J. McCann, Rosemary Godeseth, Lindsey Chudley, Ann Mander, Gianfranco Di Genova, Paul Lloyd-Evans, Jonathan P. Kerr, Vladimir B. Malykh, Matthew W. Jenner, Kim H. Orchard, Freda K. Stevenson, Christian H. Ottensmeier
6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice
Laura Jeanbart, Iraklis C. Kourtis, André J. van der Vlies, Melody A. Swartz, Jeffrey A. Hubbell
Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial
Yoshinari Maeda, Kiyoshi Yoshimura, Hiroto Matsui, Yoshitaro Shindo, Takao Tamesa, Yukio Tokumitsu, Noriaki Hashimoto, Yoshihiro Tokuhisa, Kazuhiko Sakamoto, Kouhei Sakai, Yutaka Suehiro, Yuji Hinoda, Koji Tamada, Shigefumi Yoshino, Shoichi Hazama, Masaaki Oka
STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice
Zili Wang, Esteban Celis
Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain
Alberto Anel, Luis Martínez-Lostao, Julián Pardo